Cutaneous Oncology News

Chlormethine gel showed efficacy in combination with corticosteroids or other treatments such as phototherapy in a cohort of patients with mycosis fungoides cutaneous T-cell lymphoma, according to the PROVe study.

The increase in melanoma incidence has been caused by multiple factors, with overdiagnosis possibly playing a role, according to a review in the Journal of the American Academy of Dermatology.

For patients undergoing skin biopsies of melanocytic lesions, selective second opinions may lead to better diagnostic accuracy and less cost compared with no second opinions or universal second opinions, according to a study.

Reflectance confocal microscopy was more effective than dermoscopy or high-frequency ultrasonography in guiding radiation treatment in a small cohort of patients with basal cell carcinoma, according to a study.

Pembrolizumab extended RFS compared with high-dose interferon or ipilimumab as adjuvant therapy for patients with high-risk melanoma, according to randomized phase 3 study results presented during the virtual ASCO Annual Meeting.

Sun exposure can cause deadly skin cancers, and as summer heats up and more people begin to take advantage of the outdoors, it is important to highlight the dangers of harmful UV rays.

Klisyri has received a positive opinion for the treatment of actinic keratosis from the European Medicines Agency’s Committee for Medicinal Products for Human Use, Almirall announced in a press release.

Treatment of melanoma in situ with Mohs micrographic surgery may have better outcomes than treatment with wide local excision, according to a study presented at AAD VMX 2021.

The FDA has granted breakthrough device designation to DermaSensor for its skin cancer detection device, the company announced in a press release.

Treatment with synthetic hypericin produced significant index lesion response in patients with early-stage mycosis fungoides cutaneous T-cell lymphoma, according to a study presented at AAD VMX 2021.